Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Cynomolgus Fc gamma RIII/CD16 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Supplier: R&D Systems™ 9224FC050
This item is not returnable.
View return policy
Description
The Recombinant Cynomolgus Fc gamma RIII/CD16 Protein is derived from HEK293. The Recombinant Cynomolgus Fc gamma RIII/CD16 Protein has been validated for the following applications: Bioactivity.Order Info
The product is shipped at ambient temperature.
Specifications
NP_001270121 | |
Lyophilized from a 0.2μm filtered solution in PBS and NaCl | |
36 to 44 kDa, reducing conditions | |
Human embryonic kidney cell,HEK293-derived cynomolgus monkey Fc gamma RIII (CD16) protein Gly17-Gln208,with a C-terminal 6-His tag | |
RUO | |
0.15 to 0.9ng/mL (ED 50) | |
Unconjugated | |
Recombinant | |
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining. |
Bioactivity | |
1490 | |
25μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
<0.10 EU per 1μg of protein by LAL method | |
Recombinant protein | |
Cynomolgus Monkey | |
No |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?
Provide Content Correction